Fingerprint
Dive into the research topics of 'Phase 2 study of pemetrexed plus carboplatin, or pemetrexed plus cisplatin with concurrent radiation therapy followed by pemetrexed consolidation in patients with favorable-prognosis inoperable stage IIIA/B non-small-cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically